Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IL-6 anticorps

L’anticorps Lapin Polyclonal anti-IL-6 a été validé pour WB, IF, IHC (p), EIA et Func. Il convient pour détecter IL-6 dans des échantillons de Humain.
N° du produit ABIN181728

Aperçu rapide pour IL-6 anticorps (ABIN181728)

Antigène

Voir toutes IL-6 (IL6) Anticorps
IL-6 (IL6) (Interleukin 6 (IL6))

Reactivité

  • 212
  • 134
  • 75
  • 30
  • 27
  • 22
  • 15
  • 13
  • 9
  • 8
  • 5
  • 5
  • 4
  • 3
  • 2
Humain

Hôte

  • 211
  • 107
  • 76
  • 16
  • 6
  • 3
  • 3
  • 2
Lapin

Clonalité

  • 234
  • 185
  • 2
Polyclonal

Conjugué

  • 231
  • 66
  • 28
  • 15
  • 13
  • 9
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp IL-6 est non-conjugé

Application

  • 301
  • 143
  • 136
  • 74
  • 70
  • 69
  • 54
  • 41
  • 41
  • 32
  • 25
  • 24
  • 20
  • 20
  • 16
  • 10
  • 7
  • 6
  • 6
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA), Functional Studies (Func)
  • Purification

    Affinity Chromatography employing immobilized hIL-6 matrix

    Immunogène

    Highly pure (>98%) E.coli derived recombinant Human Interleukin 6.
  • Indications d'application

    Neutralization: To yield one-half maximal inhibition [ND50] of the biological activity ofhIL-6 (1.0 ng/mL), a concentration of 0.20 - 0.40 μg/mL of this antibody is required. ELISA: Indirect: To detect hIL-6 (using 100 μL/well antibody solution) a concentration of0.5 - 2.0 μg/mL of this antibody is required. In conjunction with compatible secondaryreagents, it allows the detection of at least 0.2 - 0.4 ng/well of recombinant hIL-6. Sandwich: To detect hIL-6 (using 100 μL/well antibody solution) a concentration of0.5 - 2.0 μg/mL of this antibody is required. In conjunction with Biotinylated Anti-HumanIL-6 as a detection antibody, it allows the detection of at least 0.2 - 0.4 ng/well ofrecombinant hIL-6. Western blot: To detect hIL-6 this antibody can be used at a concentration of0.1 - 0.2 μg/mL. Used in conjunction with compatible secondary reagents the detectionlimit for recombinant hIL-6 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing

    Restrictions

    For Research Use only
  • Reconstitution

    Centrifuge vial prior to opening. Restore in sterile water to a concentration of 0.1-1.0 mg/mL.

    Buffer

    PBS, pH 7.2 without preservatives

    Agent conservateur

    Without preservative

    Conseil sur la manipulation

    Avoid repeated freezing and thawing.

    Stock

    4 °C/-20 °C

    Stockage commentaire

    Prior to reconstitution store at 2-8 °C. Following reconstitution store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène

    IL-6 (IL6) (Interleukin 6 (IL6))

    Autre désignation

    Interleukin-6 (IL6)

    Sujet

    Interleukin 6 (IL6) is a multifunctional 24 kDa protein originally discovered in the medium of RNA stimulated fibroblastoid cells. It is upregulated by IL1, TNF, PDGF, IFN beta, TNF alpha, NGF, IL17 and downregulated by glucocorticoids IL4, TGF beta. IL6 appears to be directly involved in the responses that occur after infection and cellular injury, and it may prove to be as important as IL1 and TNF alpha in regulating the acute phase response. IL6 has also been implicated in regulating adipose mass. IL6 is reported to be produced by fibroblasts, activated T cells, activated monocytes or macrophages and endothelial cells. It acts upon a variety of cells including fibroblasts, myeloid progenitor cells, T cells, B cells and hepatocytes. In addition, IL6 appears to interact with IL2 in the proliferation of T lymphocytes. IL6 potentiates the proliferative effect of IL3 on multipotential hematopoietic progenitors.Synonyms: B-cell stimulatory factor 2, BSF-2, CDF, CTL differentiation factor, Hybridoma growth factor, IFNB2, IL-6, Interferon beta-2

    ID gène

    9606

    UniProt

    P05231

    Pathways

    Signalisation TLR, Hormone Transport, Negative Regulation of Hormone Secretion, Myometrial Relaxation and Contraction, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Regulation of Carbohydrate Metabolic Process, Autophagy, Cell RedoxHomeostasis, Cancer Immune Checkpoints, Inflammasome
Vous êtes ici:
Blank Blank Blank Blank
Blank Blank Blank Blank
Chat with us!